Key points are not available for this paper at this time.
Elevated circulating FGF-23 levels and defects in skeletal mineralization early in the course of CKD suggest that factors other than the traditional markers of mineral deficiency play a crucial role in the development of renal bone disease.
Wesseling‐Perry et al. (Fri,) studied this question.